Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002646)

(Analysis AN004318)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14
taurohyodeoxycholate	ME626892	0.53	0.33	1.15	0.67	1.85	0.23	2.73	1.25	2.47	1.38	0.54	1.02	0.48	0.30
tauroursodeoxycholate	ME626893	0.55	0.32	1.09	0.67	1.74	0.22	2.72	1.29	2.60	1.39	0.54	1.06	0.47	0.31
cholate	ME626889	1.11	0.10	0.88	0.61	3.23	1.35	1.66	0.09	1.49	1.20	1.32	0.04	1.48	0.21
chenodeoxycholate	ME626884	0.98	0.67	0.28	0.34	3.55	0.48	2.49	0.68	2.07	0.99	1.03	0.90	0.67	0.93
hyodeoxycholate	ME626882	0.45	0.30	0.78	0.59	4.52	0.43	1.89	1.02	2.23	0.94	0.44	0.89	0.73	0.46
ursodeoxycholate	ME626883	0.51	0.34	0.91	0.71	4.13	0.41	1.81	0.89	2.05	1.04	0.54	0.74	0.88	0.39
phenyllactate	ME626846	0.48	1.15	1.33	1.01	0.80	0.26	0.49	3.28	0.58	1.32	0.41	0.74	0.60	1.73
urate	ME626847	0.90	0.58	0.89	1.16	2.12	3.29	0.88	0.42	0.62	0.46	0.80	0.59	0.82	0.68
tauro-alpha-muricholate	ME626896	1.92	0.69	1.06	0.88	0.94	0.33	1.39	0.47	1.20	0.73	1.66	0.71	1.72	0.83
glycocholate	ME626890	1.86	0.94	1.09	0.87	0.38	0.39	1.71	0.27	1.03	0.84	1.64	0.26	2.10	0.97
glycohyocholate	ME626891	1.86	0.94	1.09	0.87	0.40	0.37	1.72	0.27	1.03	0.84	1.65	0.25	2.11	0.97
retinoate	ME626877	0.80	2.56	1.40	0.81	1.14	0.66	0.85	0.75	1.08	1.83	1.18	0.50	1.11	0.48
FA(20:5(5Z,8Z,11Z,14Z,17Z)))	ME626878	0.89	1.52	1.33	1.01	2.72	0.56	0.86	0.72	0.79	0.97	1.43	1.30	0.95	0.88
alpha-muricholate	ME626887	0.94	0.91	0.91	0.97	2.91	1.32	0.66	0.48	0.34	0.89	1.11	0.57	1.12	1.15
omega-muricholate	ME626888	0.93	0.91	0.89	0.98	3.09	1.22	0.66	0.49	0.38	0.89	1.10	0.57	1.10	1.15
lactate	ME626828	1.01	0.66	1.14	0.92	1.89	2.02	1.12	0.76	0.95	0.62	0.89	0.87	1.65	0.66
malate	ME626838	0.93	0.71	0.84	1.38	1.77	1.61	0.83	0.65	0.78	0.64	0.76	0.80	0.97	0.75
beta-muricholate	ME626886	0.81	0.74	0.82	1.02	2.16	1.50	0.73	0.52	0.63	1.41	0.98	0.55	0.98	1.14
hippurate	ME626852	0.98	0.82	0.85	0.87	2.36	1.88	0.66	0.40	0.75	0.73	0.82	0.79	1.12	0.98
3-hydroxybutyrate	ME626830	1.45	0.49	0.92	1.50	1.69	0.84	1.40	0.49	1.58	0.60	0.85	0.63	1.43	0.58
deoxycholate	ME626885	0.76	0.67	0.93	0.76	2.15	1.28	1.75	0.60	1.54	0.83	1.01	0.76	0.56	0.77
tauro-alpha-muricholate + tauro-beta-muricholiate	ME626895	1.59	1.21	1.11	1.04	0.67	0.29	0.93	0.60	0.73	1.08	1.32	1.07	1.05	1.54
tauro-beta-muricholate	ME626894	1.47	1.47	1.09	1.13	0.42	0.26	0.75	0.67	0.49	1.25	1.14	1.29	0.74	1.97
kynurenate	ME626857	0.72	0.87	1.21	0.56	0.84	0.74	1.96	1.02	0.60	0.99	1.18	0.94	1.45	1.46
FA(22:5)	ME626880	1.01	1.20	1.45	1.09	1.06	0.50	1.34	0.88	1.68	1.19	1.32	0.75	1.05	0.93
FA(16:0-COOH)	ME626875	0.89	0.72	1.44	2.00	1.32	1.00	0.94	0.75	0.89	0.77	0.77	0.64	0.80	0.78
FA(10:0-OH)	ME626856	0.83	0.89	1.63	1.34	1.29	0.92	0.96	0.92	0.93	0.84	0.84	0.93	0.83	0.87
FA(8:0-COOH)	ME626851	0.83	0.87	1.78	1.17	0.79	0.94	0.94	0.89	0.88	0.87	0.92	0.95	0.89	0.87
FA(12:0)	ME626860	0.64	0.96	2.22	1.45	0.93	0.94	0.83	0.76	0.77	0.98	0.79	0.65	0.92	0.76
FA(10:0-COOH)	ME626861	0.74	0.73	1.94	1.78	1.20	1.23	0.69	0.66	0.74	0.70	0.66	0.65	0.76	0.71
FA(11:0-COOH)	ME626865	0.72	0.72	1.96	1.82	1.01	0.91	0.80	0.88	0.82	0.78	0.70	0.71	0.72	0.66
FA(9:0-COOH)	ME626855	0.78	0.80	1.85	1.53	1.12	1.01	0.83	0.86	0.86	0.85	0.79	0.76	0.80	0.75
FA(12:0-OH)	ME626866	0.86	1.00	1.36	1.41	0.51	0.97	0.89	1.31	0.89	1.20	0.84	1.04	0.96	1.16
FA(19:1)	ME626876	0.54	1.10	1.25	1.70	0.51	1.17	0.70	1.06	0.66	1.25	0.75	1.13	0.63	1.31
m-hydroxybenzoate	ME626840	0.73	1.05	1.42	1.02	1.45	0.94	0.59	0.89	0.54	0.84	0.67	1.04	1.58	1.10
uridine	ME626869	0.85	0.77	0.95	1.13	1.02	2.03	0.88	0.60	0.77	0.57	0.97	0.72	1.34	0.66
2-hydroxybutyrate	ME626829	1.06	0.88	0.93	1.33	0.87	1.46	1.07	0.73	1.14	0.82	0.67	0.73	0.94	0.69
N-acetylleucine	ME626849	1.09	0.87	1.07	1.12	0.87	1.58	0.99	0.71	0.82	0.68	0.83	0.77	1.20	0.83
FA(18:4)	ME626873	1.07	1.01	1.18	0.74	1.78	0.48	1.01	0.81	0.89	0.89	1.30	1.18	1.46	0.85
FA(18:3)	ME626874	0.91	1.19	1.20	1.05	1.15	0.86	0.97	0.76	0.79	1.08	1.32	0.92	1.15	0.76
FA(22:6(4Z,7Z,10Z,16Z,19Z))	ME626879	1.05	1.29	1.51	1.13	1.61	0.75	1.05	0.80	1.11	0.97	1.28	0.76	1.03	0.94
sphingosine-1P (C18)	ME626881	1.11	1.01	1.39	1.03	1.08	0.78	0.90	1.06	0.96	1.48	1.04	1.29	0.81	1.40
glutamate	ME626842	1.20	1.18	1.09	0.77	0.71	1.26	0.99	1.08	1.09	1.03	1.19	1.25	1.41	1.33
phenylalanine	ME626845	1.03	1.21	1.12	0.91	1.01	1.30	1.08	1.06	1.00	1.05	1.06	1.15	1.12	1.35
threonine	ME626833	1.07	1.16	0.96	0.63	1.03	1.24	0.94	1.03	0.87	1.06	0.95	1.06	1.13	1.21
serine	ME626831	1.28	1.11	1.09	0.99	0.86	0.81	1.33	1.05	1.16	1.18	1.23	1.07	1.19	1.14
glutamine	ME626841	1.22	1.05	0.99	1.13	1.00	0.80	1.29	1.19	1.23	1.15	1.12	1.08	1.17	1.01
histidine	ME626843	1.12	1.09	1.00	1.18	1.03	1.02	1.20	1.12	1.21	1.11	1.15	1.06	1.13	0.93
aspartate	ME626837	0.98	1.14	0.92	0.93	0.69	0.83	1.05	1.20	1.00	1.15	1.05	1.16	0.99	1.12
deoxycytidine	ME626868	1.03	1.21	1.14	0.92	0.35	0.85	1.01	1.18	1.05	1.27	0.92	1.10	0.82	1.11
taurine	ME626834	1.03	1.07	0.91	1.25	1.27	1.31	1.00	1.08	1.01	1.06	1.04	1.04	1.04	1.10
N-acetylphenylalanine	ME626864	0.85	1.06	0.89	1.25	1.05	1.14	0.86	0.87	0.87	0.94	0.91	0.92	0.95	1.14
tyrosine	ME626853	0.99	1.09	0.94	1.02	0.98	0.93	1.01	0.97	0.98	1.01	0.97	1.05	0.94	1.20
citrate	ME626859	1.04	0.94	1.01	0.97	1.20	1.17	0.92	0.97	0.95	0.97	0.84	0.98	0.99	1.02
gamma-glutamylleucine	ME626871	1.10	1.11	1.05	0.86	0.94	1.17	0.89	1.05	0.94	1.02	0.88	1.04	0.97	1.01
FA(10:0)	ME626848	0.72	0.88	1.10	1.24	0.99	0.86	1.08	0.97	1.01	1.09	0.94	0.99	1.04	0.84
FA(14:0-OH)	ME626870	0.88	1.01	1.37	1.42	0.98	0.82	0.97	1.12	0.88	1.10	0.80	1.01	0.89	1.13
FA(14:2)	ME626867	0.71	0.95	1.08	1.26	0.88	1.08	0.90	0.99	0.83	1.10	0.98	1.04	0.87	0.90
FA(16:0-OH)	ME626872	0.87	0.99	1.33	1.32	0.93	1.09	0.87	1.12	0.90	1.11	0.96	1.10	0.78	1.04
FA(8:0-OH)	ME626844	0.83	1.07	1.21	1.14	0.90	1.12	0.82	1.00	0.82	1.07	0.75	0.99	0.83	1.07
3-methyl-2-oxovalerate	ME626835	1.25	0.80	0.95	0.86	1.24	1.13	1.15	0.82	1.09	0.90	0.83	0.89	1.28	0.98
ketoleucine	ME626836	1.25	0.82	1.01	0.86	1.27	0.95	1.12	0.86	1.04	0.95	0.91	0.97	1.23	0.99
hydroxyindole acetate	ME626858	0.93	1.28	1.10	0.88	1.34	1.12	1.09	0.87	0.60	0.90	0.76	0.93	0.98	1.31
indole lactate	ME626863	0.81	0.83	0.90	0.99	1.71	1.46	0.82	0.86	0.91	0.92	0.80	1.00	0.96	0.96
hydroxyphenyllactic acid	ME626854	0.83	1.08	0.96	0.94	1.35	1.32	0.80	0.85	0.79	0.92	0.85	1.00	0.99	1.29
phenylacetate	ME626839	0.89	0.99	0.97	0.99	1.36	1.39	0.82	0.83	0.85	0.89	0.82	0.96	0.97	1.16
tryptophan	ME626862	1.07	0.86	0.95	0.88	1.48	1.47	1.03	0.77	1.01	0.78	0.85	0.85	1.06	0.93
cis-aconitate	ME626850	1.07	0.95	1.02	0.77	1.15	1.34	0.84	0.98	0.85	0.94	0.91	1.00	1.19	1.09
maleate	ME626832	1.02	0.96	0.98	0.76	1.30	1.47	0.96	0.87	0.88	0.83	0.90	0.99	1.19	0.97

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-DriftCorrection \| Timepoint:0 hour \| Sex:-
F4	Group:QC-Pooled \| Timepoint:0 hour \| Sex:-
F5	Group:QC-ReCAS \| Timepoint:0 hour \| Sex:-
F6	Group:QC-Reference \| Timepoint:0 hour \| Sex:-
F7	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F8	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F9	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F10	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F11	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F12	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F13	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F14	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix